A delegation of 14 EIC-backed companies will participate in EIC Soft-landing Programme for healthcare and life sciences, taking place from 9 to 13 June in Boston, US. As an initiative of the EIC Business Acceleration Services, , the programme will give EIC innovators the opportunity to expand their technologies overseas, offering them tailored services and the right guidance and tools to connect and build international partnerships. For this edition, the programme is partnering with MIT LinQ to provide the selected EIC companies with additional guidance from a structured innovation methodology focusing on medical innovation.
The mission’s agenda will include targeted market insights sessions and warm introductions to the most relevant stakeholders within the Boston ecosystem, including high level investors, corporates and other potential business partners. During the programme, the selected EIC-backed companies will strive to accelerate their impact by identifying unmet medical needs, enhancing strategic decision-making, and making the most out of their new connections with the right partners for their business.
Take a look at the highlights from the last edition on health and life sciences in this recap video.
Meet the delegation to Boston
The 14 EIC-backed companies for this Soft-landing mission to Boston are:
- ADmit Therapeutics (Spain): Early Alzheimer's detection, for a future of personalised and precision medicine.
- AkknaTek (Germany): Accurate lens implantation for premium intraocular lens implants.
- BestHealth4U (Portugal) Bio2Skin offers strong and reliable adhesion while being gentle on the skin.
- FineHeart (France): To become the gold standard in treating mechanical heart failure support.
- Hemispherian (Norway): GLIX1 is an entirely new way of treating brain cancers.
- iLoF (Portugal): Using AI and light tech for faster, affordable personalised accessible medicine.
- moveUP (Belgium): Transforming patient experiences and optimising healthcare delivery.
- MYSPHERA (Spain): Raising surgical throughput by automating coordination and lowering downtime.
- NETRIS Pharma (France): Developing therapy to overcome resistance in oncology by targeting Netrin-1.
- Neogap Therapeutics (Sweden) : Cancer treatment targeting cancer cells while preserving healthy tissue.
- O11 biomedical (Germany): Lowering CO2 levels in COPD patients, simply by drinking RESPILIQ™.
- Surgify Medical (Finland): Pioneering tissue-specific bone removal system based on the HaloSense tech.
- TILT Biotherapeutics (Finland): Creating the next generation of immunotherapies for solid tumours.
- Time is Brain (Spain): Automated brain monitoring for faster, equitable and accurate stroke treatment.
On 14 April, an online pre-departure onboarding meeting was held with the 14 EIC-backed companies, EIC representatives, and coaching experts. The purpose of the meeting was to prepare the selected companies for the Soft-landing mission to Boston by providing detailed information about the programme’s matchmaking services and outlining the activities planned for the onsite event.
In the lead-up to their immersion week, these EIC invested in additional coaching through six targeted workshops, various matchmaking activities designed to enhance companies readiness and networking opportunities. These include pitch training, partner networking strategies in Boston, a leadership workshop with Spentys’ CEO, a testimony from MelliCell on chronic disease therapeutics, an innovation overview with Rice Venture Fund’s Adrian Trömel, and a session on legal and financing considerations for expanding into the US. This immersive initiative is happening one week before one of the world’s largest biotech conference, the BIO International Convention 2025, scheduled from 16-19 June 2025 in Boston, USA where 15 EIC companies exhibit at the EIC Pavilion to extend their business opportunities and develop more connections with biotech leaders and potential investors in the region and at global level.
Stay up to date via the EIC Community Platform and the EIC Business Acceleration Services newsletter.
Should you have any questions on the programme, please do not hesitate to contact us through the EIC Community Helpdesk by selecting "EVENT – EIC ITF Programme – by selecting "EVENT – EIC ITF Programme – Soft-landing Boston 2025" as the subject in the "Category" field. 2025" as the subject in the "Category" field.
The EIC Soft-landing programme is an initiative of the EIC Business Acceleration Services.
Be the first to receive the latest updates on open calls for applications, inspiring success stories, exclusive interviews, partner opportunities, and other engaging news from the EIC Business Acceleration Services with the EIC BAS Newsletter.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.